Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase 1 2Phase EARLY_PHASE1 1

Status

Completed 20Terminated 5Unknown 4Withdrawn 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 120Neoplasms 75Prostatic Neoplasms 70Lung Neoplasms 36Carcinoma, Non-Small-Cell Lung 33Pancreatic Neoplasms 32Colorectal Neoplasms 32Head and Neck Neoplasms 29Carcinoma, Hepatocellular 24Brain Neoplasms 24Colonic Neoplasms 22Motor Activity 19Carcinoma, Renal Cell 18Pain 16Ovarian Neoplasms 16Neoplasm Metastasis 14Hematologic Neoplasms 14Urinary Bladder Neoplasms 13Rectal Neoplasms 13Lymphoma, Follicular 13Fatigue 13Sarcoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Glioblastoma 12Lymphoma 11Liver Neoplasms 11Glioma 11Squamous Cell Carcinoma of Head and Neck 10Leukemia 10Anxiety Disorders 10

Interventions

Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Withdrawn × Breast Neoplasms, Male × Clear all
NCT00999557 2020-07-31

Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants

Jonsson Comprehensive Cancer Center

Phase NA Withdrawn
Breast

Alopecia, Breast Neoplasms, Breast Neoplasms, Male

NCT01939483 2014-10-08

A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases

University of California, Irvine

Phase NA Withdrawn
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡